Previous 10 | Next 10 |
home / stock / nvsef / nvsef news
The broader markets are on a path to recovery for more than a week now, even though the fate of the economy hangs in the balance. Most of the country is still in shutdown mode, and it's likely to cost trillions of dollars when all is said and done. Some estimates are as high as $10 trillion....
Biomarin ( BMRN ) was able to get its Biologics License Application (BLA) accepted by the FDA for its AAV5 gene therapy vaccine known as valoctocogene roxaparvovec. It was given Priority Review by the FDA for the treatment of patients with severe Hemophilia A. With the application being ...
New York City, NY: April 07, 2020 – Recent Research and Future Market Potential of Digestive System Drug Market in Global Industry: 2020 Research and New Innovations in Chemicals and Materials Sector. The prime objective of the report is to offer updates and information related to futu...
The largest profits in the investment field go to those who are capable of correctly zigging when the financial community is zagging. - Phillip Fisher As you know, the coronavirus pandemic spooked the overall stock market. With the market in a panic mode , the downdraft carries Regenxb...
Bull markets are born on pessimism, grown on skepticism, mature on optimism and die on euphoria. - Sir John Templeton One of the best times for you to invest in a stock is when it tumbled far below its true worth. This usually occurs during a downturn like this Corona bear market. Howeve...
Introduction It is remarkable how few articles have been published about Genfit ( GNFT) lately on Seeking Alpha. The last articles dated from June and August last year. This is quite remarkable since the company is nearing its make-or-break moment and indicates that investors’ ...
This article is part of a series that provides an ongoing analysis of the changes made to Tweedy Browne's 13F portfolio on a quarterly basis. It is based on Tweedy Browne's regulatory 13F Form filed on 02/14/2020. Please visit our Tracking Tweedy Browne Portfolio series to get an idea of t...
ETF Overview iShares Global Healthcare ETF (IXJ) owns a portfolio of large-cap healthcare stocks in the world. The ETF tracks the investment results of the S&P Global 1200 Health Care Index. Stocks in IXJ's portfolio should benefit from an ageing population in the world in the next few d...
Quick Take NLS Pharmaceutics ( NLSP ) has filed to raise $40.25 million in an IPO of its common stock, according to an F-1 registration statement . The company is advancing a pipeline of drug candidates for the treatment of various central nervous system disorders. NLSP expects to begin...
Introduction Precision BioSciences ( DTIL ) is a genome editing company dedicated to improving life through their proprietary genome editing platform (“ARCUS”), where they are developing product candidates in three high-value areas: allogeneic CAR T immunotherapy, in vivo g...
News, Short Squeeze, Breakout and More Instantly...
Novartis Ag Basel Akt Company Name:
NVSEF Stock Symbol:
OTCMKTS Market:
Novartis Ag Basel Akt Website:
FDA approval of the company’s second US Radioligand Therapy (RLT) manufacturing facility increases RLT production capacity to 250,000 doses in 2024 and beyond New 70,000-square foot RLT facility is the company’s largest and most advanced in the world to date and centrall...
APPLY-PNH extension data show that continuous Fabhalta ® (iptacopan) treatment in adults with paroxysmal nocturnal hemoglobinuria (PNH) enabled sustained hemoglobin-level increases to near-normal (≥12 g/dL), blood transfusion avoidance, and improved patient-reported fatigu...
With 5.6 months of additional follow-up and 78.3% of patients having completed Kisqali ® (ribociclib) investigational treatment, the updated analysis shows sustained iDFS benefit and stability in secondary endpoints including overall survival (OS) 1,2 iDFS...